by GMFH Editing Team
Bernd Schnabl is an Associate Professor in Gastroenterology at University of California San Diego School of Medicine, where he investigates precisely the pathogenesis of chronic liver disease. He attended the 5th Gut Microbiota for Health World Summit 2016.
by Andreu Prados
It is already known that a reduction in gut microbial richness is the hallmark change of human immunodeficiency virus (HIV) infection, but how this dysbiosis is established in the HIV-exposed uninfected infant is poorly understood. A recent cross-sectional study, led by Dr. Grace M. Aldrovandi from the Children’s Hospital Los Angeles in Los Angeles (USA), suggests that perturbations in the infant gut microbiome may explain the greater risk of morbidity and mortality in uninfected babies born to HIV-positive mothers.
by GMFH Editing Team
Researcher Omry Koren, from Bar Ilan University, in Israel, studies what happens to microbiota along gestation and whether it can be positively impacted with the use of prebiotics and probiotics in order to prevent any complications.
by Andreu Prados
A recent study, led by Dr. Yue Zeng from the Department of Gastroenterology at Shanghai Jiao Tong University School of Medicine in Shanghai (China), has found that colorectal pre-neoplasic lesions may be the most important factor leading to mucosal adherent bacterial dysbiosis in patients with colorectal adenomas.
